Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke

Yue Zhang1, Jiaying Li1, Yongfang Zhao1

  • 1Department of Critical Care Medicine of Huashan Hospital, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, China.

Science Advances
|March 6, 2024
PubMed

Insights

Histone deacetylase 3 (HDAC3) inhibition in microglia improves outcomes after ischemic stroke by reducing harmful inflammation. This occurs by blocking the proliferation of pro-inflammatory microglia via the PU.1 pathway.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglial polarization and accumulation in the penumbra are key to neuroinflammation post-ischemic stroke, causing neuronal damage.
  • Histone deacetylase 3 (HDAC3) regulates inflammation and cell proliferation, but its specific role in microgliosis and polarization after stroke is unknown.

Purpose of the Study:

  • To investigate the role of HDAC3 in microglial polarization and its impact on ischemic stroke pathophysiology.
  • To elucidate the molecular mechanisms by which HDAC3 influences microglial responses and stroke outcomes.

Main Methods:

  • Generated microglial-specific HDAC3 knockout (HDAC3-miKO) mice.
  • Performed RNA-sequencing (RNA-seq) and ATAC-sequencing (ATAC-seq) on microglia post-stroke.
  • Utilized adeno-associated virus (AAV) to overexpress PU.1 in microglia.

Main Results:

  • HDAC3-miKO significantly improved long-term functional and histological outcomes after ischemic stroke.
  • HDAC3 deficiency in microglia primarily affected mitotic processes, specifically inhibiting the proliferation of pro-inflammatory microglia.
  • HDAC3-miKO altered chromatin accessibility at PU.1 motifs, and PU.1 overexpression reversed the protective effects of HDAC3-miKO.

Conclusions:

  • The HDAC3/PU.1 axis plays a critical role in regulating microglial proliferation and polarization post-stroke.
  • Targeting HDAC3 in microglia offers a potential therapeutic strategy to mitigate neuroinflammation and improve recovery after ischemic stroke.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...